Memantine Hydrochloride
- Product NDC
- 71335-0346
- Requested package NDC
- 71335-0346-2
- 11-digit product format
- 713350346
- Labeler code
- 71335
- Product ID
- 71335-0346_1183728c-e0ed-4c18-b157-071d94d2c38a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Memantine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA206528
- Marketing category
- ANDA
- Marketing start
- 2015-08-27
- Marketing end
- 0000-00-00
- Substance
- MEMANTINE HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 71335-0346 | 71335-0346-2 | D | Discontinued by firm | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206528-001 | MEMANTINE HYDROCHLORIDE | MEMANTINE HYDROCHLORIDE | 5MG | TABLET / ORAL | AB | 2015-11-30 | |
| A206528-002 | MEMANTINE HYDROCHLORIDE | MEMANTINE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 2015-11-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A206528-001 | AB |
| A206528-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A206528-001 | MEMANTINE HYDROCHLORIDE | 5MG | TABLET / ORAL | AB | 2015-11-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A206528-002 | MEMANTINE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 2015-11-30 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A206528-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A206528-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Memantine Hydrochloride | MEMANTINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | becb09dc-174d-4817-88d4-f38c8adcd309 | 2026-06-17 | Warnings, Adverse reactions | 206528 ANDA206528 |
| Memantine Hydrochloride | MEMANTINE HYDROCHLORIDE | Bryant Ranch Prepack | afc07196-be28-4521-afc0-d4aa5b6fd46d | 2026-05-20 | Warnings, Adverse reactions | 206528 ANDA206528 |
| Memantine Hydrochloride | MEMANTINE HYDROCHLORIDE | Ajanta Pharma USA Inc. | 292671f2-f221-4a3d-a110-a266a9527e04 | 2025-11-27 | Warnings, Adverse reactions | 206528 ANDA206528 |
| Memantine Hydrochloride | MEMANTINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 30b8b982-db74-7cf4-e063-6394a90a3a6b | 2025-03-19 | Warnings, Adverse reactions | 206528 ANDA206528 |
| Memantine HCL | MEMANTINE HCL | Direct_Rx | 1289db0e-5179-d157-e063-6294a90ab758 | 2024-02-29 | Warnings, Adverse reactions | 206528 ANDA206528 |
| Memantine Hydrochloride | MEMANTINE HYDROCHLORIDE | A-S Medication Solutions | d1c2ec99-7183-46e3-a96e-4f23e20b8b06 | 2023-04-19 | Warnings, Adverse reactions | 206528 ANDA206528 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 71335-0346-2 | 71335034602 | 28 TABLET in 1 BOTTLE (71335-0346-2) | 28 tablet | 2021-12-27 | 0000-00-00 | No | No | Current |